# NR0B1

## Overview
The NR0B1 gene encodes the nuclear receptor subfamily 0 group B member 1 protein, commonly referred to as DAX1. This protein is an atypical member of the nuclear receptor superfamily, characterized by its lack of a conventional DNA-binding domain and its role as a transcriptional repressor. DAX1 is primarily involved in the regulation of steroidogenic gene expression, playing a crucial role in the development and function of steroidogenic tissues such as the adrenal gland and the hypothalamic-pituitary-gonadal axis. It interacts with other nuclear receptors, including steroidogenic factor 1 (SF1), to modulate transcriptional activity, thereby influencing processes like adrenal development and reproductive function (Iyer2004Molecular; Lalli2014Role). Mutations in NR0B1 are associated with clinical conditions such as X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, underscoring its significance in human health (Pereira2015Xlinked; Phelan2001Mutations).

## Structure
The NR0B1 gene encodes the DAX1 protein, an atypical member of the nuclear receptor superfamily. DAX1 has a unique molecular structure, lacking the conventional DNA-binding domain (DBD) and modulator domain typical of nuclear receptors. Instead, it features an amino-terminal domain (NTD) composed of 3.5 alanine/glycine-rich repeats, each 65-70 amino acids long, which include LXXLL motif-like sequences crucial for protein interactions (Suzuki2003LXXLLRelated; Iyer2004Molecular). The carboxy-terminal domain (CTD) of DAX1 is homologous to the ligand-binding domain (LBD) of other nuclear receptors and contains an AF-2 transactivation domain, although no ligand has been identified for DAX1 (Iyer2004Molecular).

DAX1 can form homodimers and heterodimers with other nuclear receptors, such as SHP (NR0B2), through its LXXLL motifs and AF-2 domain (Iyer2007LXXLL; Stickels2015DAX1NR0B1). The protein also interacts with receptors like SF1 and LRH-1, utilizing its LXXLL motifs for these interactions (Suzuki2003LXXLLRelated). DAX1 is subject to alternative splicing, resulting in isoforms such as DAX1A, which lacks the last 80 amino acids of the CTD, including the AF-2 domain (Iyer2007LXXLL). These structural features contribute to DAX1's role in transcriptional repression and its involvement in the hypothalamic-pituitary-adrenal-gonadal axis (Iyer2004Molecular).

## Function
The NR0B1 gene, also known as DAX1, encodes a nuclear receptor that functions primarily as a transcriptional repressor. It plays a critical role in the development and function of steroidogenic tissues, including the adrenal gland and the hypothalamic-pituitary-gonadal axis. DAX1 is involved in regulating the expression of genes associated with steroid hormone production and metabolism. It interacts with other nuclear receptors, such as steroidogenic factor 1 (SF1), to repress transcriptional activation, which is crucial for maintaining the balance of steroidogenic gene expression (Iyer2004Molecular; Lalli2014Role).

DAX1 is expressed in the nucleus, where it forms complexes with SF1, leading to transcriptional repression of target genes. This interaction is essential for normal adrenocortical development and function, as it helps regulate the production of mineralocorticoids, glucocorticoids, and sex steroids (Ehrlund2012Ligandindependent; Niakan2005DAX1). DAX1 also plays a role in reproductive development, influencing processes such as testis cord organization and spermatogenesis (Iyer2004Molecular). Its activity is modulated by post-translational modifications, such as mono-ubiquitination, which affect its repression potential (Ehrlund2012Ligandindependent).

## Clinical Significance
Mutations in the NR0B1 gene, also known as DAX1, are primarily associated with X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HH). These conditions result from the disruption of adrenal gland development and impaired sexual development due to the gene's role as a transcriptional repressor (Pereira2015Xlinked; Phelan2001Mutations). AHC is characterized by primary adrenal insufficiency, often presenting in infancy or childhood, and is linked to various mutations, including frameshift, nonsense, and missense mutations in the NR0B1 gene (Gupta2019Novel; Phelan2001Mutations).

The NR0B1 gene is also implicated in dosage-sensitive sex reversal (DSS) when overexpressed, as seen in cases of small duplications of Xp21, which can lead to sex reversal in XY individuals (Phelan2001Mutations). Additionally, NR0B1 mutations can cause a range of clinical manifestations, including late-onset adrenal insufficiency, mineralocorticoid deficiency, and testis dysgenesis, highlighting the phenotypic variability of the associated conditions (Pereira2015Xlinked; Suntharalingham2015DAX1). Genetic testing for NR0B1 mutations is crucial for early diagnosis and management, particularly in potential carrier mothers and their offspring (Pereira2015Xlinked).

## Interactions
NR0B1, also known as DAX1, is involved in various protein interactions that play significant roles in transcriptional regulation. It interacts directly with the EWS/FLI fusion protein, a key factor in Ewing's sarcoma. This interaction is mediated through the LXXLL motifs in the amino-terminal domain of NR0B1 and the EWS domain of EWS/FLI. Mutations in these motifs disrupt the interaction, highlighting their importance (Kinsey2009EWS/FLI). NR0B1 also interacts with steroidogenic factor 1 (SF-1), where it acts as a transcriptional repressor by recruiting the nuclear receptor corepressor N-CoR to SF-1. This interaction is crucial for the repression of SF-1 activity, and mutations in NR0B1 associated with adrenal hypoplasia congenita impair this interaction (Crawford1998Nuclear).

In addition to its repressive functions, NR0B1 can act as a transcriptional coactivator in certain contexts. It interacts with TIF2 and the steroid receptor RNA activator (SRA) to enhance the transcriptional activity of SF-1, indicating a dual role in gene regulation (Xu2009Dax1). These interactions underscore the complex regulatory functions of NR0B1 in various biological processes.


## References


[1. (Ehrlund2012Ligandindependent) Anna Ehrlund and Eckardt Treuter. Ligand-independent actions of the orphan receptors/corepressors dax-1 and shp in metabolism, reproduction and disease. The Journal of Steroid Biochemistry and Molecular Biology, 130(3–5):169–179, July 2012. URL: http://dx.doi.org/10.1016/j.jsbmb.2011.04.007, doi:10.1016/j.jsbmb.2011.04.007. This article has 26 citations.](https://doi.org/10.1016/j.jsbmb.2011.04.007)

[2. (Kinsey2009EWS/FLI) Michelle Kinsey, Richard Smith, Anita K. Iyer, Edward R.B. McCabe, and Stephen L. Lessnick. Ews/fli and its downstream target nr0b1 interact directly to modulate transcription and oncogenesis in ewing’s sarcoma. Cancer Research, 69(23):9047–9055, November 2009. URL: http://dx.doi.org/10.1158/0008-5472.can-09-1540, doi:10.1158/0008-5472.can-09-1540. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-09-1540)

[3. (Suntharalingham2015DAX1) Jenifer P. Suntharalingham, Federica Buonocore, Andrew J. Duncan, and John C. Achermann. Dax-1 (nr0b1) and steroidogenic factor-1 (sf-1, nr5a1) in human disease. Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism, 29(4):607–619, August 2015. URL: http://dx.doi.org/10.1016/j.beem.2015.07.004, doi:10.1016/j.beem.2015.07.004. This article has 182 citations.](https://doi.org/10.1016/j.beem.2015.07.004)

[4. (Phelan2001Mutations) James K. Phelan and Edward R.B. Mccabe. Mutations innr0b1 (dax1) andnr5a1 (sf1) responsible for adrenal hypoplasia congenita. Human Mutation, 18(6):472–487, 2001. URL: http://dx.doi.org/10.1002/humu.1225, doi:10.1002/humu.1225. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.1225)

[5. (Crawford1998Nuclear) Peter A. Crawford, Christoph Dorn, Yoel Sadovsky, and Jeffrey Milbrandt. Nuclear receptor dax-1 recruits nuclear receptor corepressor n-cor to steroidogenic factor 1. Molecular and Cellular Biology, 18(5):2949–2956, May 1998. URL: http://dx.doi.org/10.1128/mcb.18.5.2949, doi:10.1128/mcb.18.5.2949. This article has 242 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.18.5.2949)

[6. (Lalli2014Role) Enzo Lalli. Role of orphan nuclear receptor dax-1/nr0b1 in development, physiology, and disease. Advances in Biology, 2014:1–19, May 2014. URL: http://dx.doi.org/10.1155/2014/582749, doi:10.1155/2014/582749. This article has 22 citations.](https://doi.org/10.1155/2014/582749)

[7. (Iyer2007LXXLL) Anita K. Iyer, Yao-Hua Zhang, and Edward R.B. McCabe. Lxxll motifs and af-2 domain mediate shp (nr0b2) homodimerization and dax1 (nr0b1)–dax1a heterodimerization. Molecular Genetics and Metabolism, 92(1–2):151–159, September 2007. URL: http://dx.doi.org/10.1016/j.ymgme.2007.06.009, doi:10.1016/j.ymgme.2007.06.009. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2007.06.009)

[8. (Stickels2015DAX1NR0B1) Robert Stickels, Kevin Clark, Thomas N. Heider, Deidre M. Mattiske, Marilyn B. Renfree, and Andrew J. Pask. Dax1/nr0b1 was expressed during mammalian gonadal development and gametogenesis before it was recruited to the eutherian x chromosome1. Biology of Reproduction, January 2015. URL: http://dx.doi.org/10.1095/biolreprod.114.119362, doi:10.1095/biolreprod.114.119362. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1095/biolreprod.114.119362)

[9. (Xu2009Dax1) Bin Xu, Wei-Hsiung Yang, Isabelle Gerin, Chang-Deng Hu, Gary D. Hammer, and Ronald J. Koenig. Dax-1 and steroid receptor rna activator (sra) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Molecular and Cellular Biology, 29(7):1719–1734, April 2009. URL: http://dx.doi.org/10.1128/mcb.01010-08, doi:10.1128/mcb.01010-08. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01010-08)

[10. (Iyer2004Molecular) Anita K. Iyer and Edward R.B. McCabe. Molecular mechanisms of dax1 action. Molecular Genetics and Metabolism, 83(1–2):60–73, September 2004. URL: http://dx.doi.org/10.1016/j.ymgme.2004.07.018, doi:10.1016/j.ymgme.2004.07.018. This article has 148 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2004.07.018)

[11. (Pereira2015Xlinked) Bernardo Dias Pereira, Iris Pereira, Jorge Ralha Portugal, João Gonçalves, and Luísa Raimundo. X-linked adrenal hypoplasia congenita: clinical and follow-up findings of two kindreds, one with a novel nr0b1 mutation. Archives of Endocrinology and Metabolism, 59(2):181–185, April 2015. URL: http://dx.doi.org/10.1590/2359-3997000000032, doi:10.1590/2359-3997000000032. This article has 6 citations.](https://doi.org/10.1590/2359-3997000000032)

[12. (Suzuki2003LXXLLRelated) Taiga Suzuki, Megumi Kasahara, Hidefumi Yoshioka, Ken-ichirou Morohashi, and Kazuhiko Umesono. Lxxll-related motifs in dax-1 have target specificity for the orphan nuclear receptors ad4bp/sf-1 and lrh-1. Molecular and Cellular Biology, 23(1):238–249, January 2003. URL: http://dx.doi.org/10.1128/mcb.23.1.238-249.2003, doi:10.1128/mcb.23.1.238-249.2003. This article has 118 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.23.1.238-249.2003)

[13. (Gupta2019Novel) Suchit Gupta, Kriti Joshi, Ghazala Zaidi, Aditya Narayan Sarangi, Kausik Mandal, Nisha Bhavani, Praveen V. Pavithran, Mini G. Pillai, Surya K. Singh, Tushar Godbole, Vijayalakshmi Bhatia, and Eesh Bhatia. Novel mutations and spectrum of the disease of nr0b1 (dax1)-related adrenal insufficiency in indian children. Journal of Pediatric Endocrinology and Metabolism, 32(8):863–869, June 2019. URL: http://dx.doi.org/10.1515/jpem-2018-0440, doi:10.1515/jpem-2018-0440. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/jpem-2018-0440)

[14. (Niakan2005DAX1) K.K. Niakan and E.R.B. McCabe. Dax1 origin, function, and novel role. Molecular Genetics and Metabolism, 86(1–2):70–83, September 2005. URL: http://dx.doi.org/10.1016/j.ymgme.2005.07.019, doi:10.1016/j.ymgme.2005.07.019. This article has 69 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2005.07.019)